נאנו 24 בע"מ

Nano24 is developing a pipeline of CD24-based exosomes, aimed at treating COVID-19 with EXO-CD24, a therapeutic directly inhaled to the lungs, as well as a broad range of disease areas, spanning ARDS, respiratory and autoimmune disease.

Physicians, People with ARDS, Respiratory and Autoimmune disease.